Phenotypical changes of hematopoietic stem
and progenitor cells in COVID-19 patients:
Correlation with disease status

Hosni A. M. Hussein; Ali A. A. Thabet; Taha I. A. Mohamed; Mohamed E. Elnosary; Ali Sobhy; Ahmed M. El-Adly; Ahmed A. Wardany; Elsayed K. Bakhiet; Magdy M. Afifi; Usama M. Abdulraouf; Samah . M. Fathy; Noha G. Sayed; Asmaa M. Zahran

doi:10.5114/ceji.2023.129981

eISSN: 1644-4124
ISSN: 1426-3912

Central European Journal of Immunology

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors

Editorial System

Submit your Manuscript

2/2023
vol. 48

Send email

Copy url:

abstract:

Clinical immunology

Phenotypical changes of hematopoietic stem and progenitor cells in COVID-19 patients: Correlation with disease status

Hosni A. M. Hussein

¹

,

Ali A. A. Thabet

²

,

Taha I. A. Mohamed

¹

,

Mohamed E. Elnosary

³

,

Ali Sobhy

⁴

,

Ahmed M. El-Adly

¹

,

Ahmed A. Wardany

¹

,

Elsayed K. Bakhiet

¹

,

Magdy M. Afifi

¹

,

Usama M. Abdulraouf

¹

,

Samah . M. Fathy

⁵

,

Noha G. Sayed

⁶

,

Asmaa M. Zahran

⁶

Department of Botany and Microbiology, Faculty of Science, Al-Azhar University, Assiut, Egypt
Department of Zoology, Faculty of Science, Al-Azhar University, Assiut, Egypt
Department of Botany and Microbiology, Faculty of Science, Al-Azhar University, Nasr City, Cairo, Egypt
Department of Clinical Pathology, Faculty of Medicine, Al-Azhar University, Assiut, Egypt
Department of Zoology, Faculty of Science, Fayoum University, Fayoum, Egypt
Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt

Cent Eur J Immunol 2023; 48 (2): 97-110

DOI: https://doi.org/10.5114/ceji.2023.129981

Online publish date: 2023/07/17

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Hussein H, Thabet A, Mohamed T, et al. Phenotypical changes of hematopoietic stem
and progenitor cells in COVID-19 patients:
Correlation with disease status. Central European Journal of Immunology. 2023;48(2):97-110. doi:10.5114/ceji.2023.129981.

APA

Hussein, H., Thabet, A., Mohamed, T., Elnosary, M., Sobhy, A.,  & El-Adly, A. et al. (2023). Phenotypical changes of hematopoietic stem
and progenitor cells in COVID-19 patients:
Correlation with disease status. Central European Journal of Immunology, 48(2), 97-110. https://doi.org/10.5114/ceji.2023.129981

Chicago

Hussein, Hosni A. M., Ali A. A. Thabet, Taha I. A. Mohamed, Mohamed E. Elnosary, Ali Sobhy, Ahmed M. El-Adly,  and Ahmed A. Wardany et al. 2023. "Phenotypical changes of hematopoietic stem
and progenitor cells in COVID-19 patients:
Correlation with disease status". Central European Journal of Immunology 48 (2): 97-110. doi:10.5114/ceji.2023.129981.

Harvard

Hussein, H., Thabet, A., Mohamed, T., Elnosary, M., Sobhy, A., El-Adly, A., Wardany, A., Bakhiet, E., Afifi, M., Abdulraouf, U., Fathy, S., Sayed, N.,  and Zahran, A. (2023). Phenotypical changes of hematopoietic stem
and progenitor cells in COVID-19 patients:
Correlation with disease status. Central European Journal of Immunology, 48(2), pp.97-110. https://doi.org/10.5114/ceji.2023.129981

MLA

Hussein, Hosni A. M. et al. "Phenotypical changes of hematopoietic stem
and progenitor cells in COVID-19 patients:
Correlation with disease status." Central European Journal of Immunology, vol. 48, no. 2, 2023, pp. 97-110. doi:10.5114/ceji.2023.129981.

Vancouver

Hussein H, Thabet A, Mohamed T, Elnosary M, Sobhy A, El-Adly A et al. Phenotypical changes of hematopoietic stem
and progenitor cells in COVID-19 patients:
Correlation with disease status. Central European Journal of Immunology. 2023;48(2):97-110. doi:10.5114/ceji.2023.129981.

PlumX metrics:

Hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) play a crucial role in the context of viral infections and their associated diseases. The link between HSCs and HPCs and disease status in COVID-19 patients is largely unknown. This study aimed to monitor the kinetics and contributions of HSCs and HPCs in severe and non-severe COVID-19 patients and to evaluate their diagnostic performance in differentiating between healthy and COVID-19 patients as well as severe and non-severe cases. Peripheral blood (PB) samples were collected from 48 COVID-19 patients, 16 recovered, and 27 healthy controls and subjected to deep flow cytometric analysis to determine HSCs and progenitor cells. Their diagnostic value and correlation with C-reactive protein (CRP), D-dimer, and ferritin levels were determined. The percentages of HSCs and common myeloid progenitors (CMPs) declined significantly, while the percentage of multipotent progenitors (MPPs) increased significantly in COVID-19 patients. There were no significant differences in the percentages of megakaryocyte-erythroid progenitors (MEPs) and granulocyte-macrophage progenitors (GMPs) between all groups. Severe COVID-19 patients had a significantly low percentage of HSCs, CMPs, and GMPs compared to non-severe cases. Contrarily, the levels of CRP, D-dimer, and ferritin increased significantly in severe COVID-19 patients. MPPs and CMPs showed excellent diagnostic performance in distinguishing COVID-19 patients from healthy controls and severe from non-severe COVID-19 patients, respectively. Collectively, our study indicated that hematopoietic stem and progenitor cells are significantly altered by COVID-19 and could be used as therapeutic targets and diagnostic biomarkers for severe COVID-19.

keywords:

Phenotypical changes of hematopoietic stem and progenitor cells in COVID-19 patients: Correlation with disease status

Hosni A. M. Hussein 1 , Ali A. A. Thabet 2 , Taha I. A. Mohamed 1 , Mohamed E. Elnosary 3 , Ali Sobhy 4 , Ahmed M. El-Adly 1 , Ahmed A. Wardany 1 , Elsayed K. Bakhiet 1 , Magdy M. Afifi 1 , Usama M. Abdulraouf 1 , Samah . M. Fathy 5 , Noha G. Sayed 6 , Asmaa M. Zahran 6

COVID-19, SARS-CoV-2, hematopoietic stem cells (HSCs), hematopoietic progenitor cells (HPCs)